A carregar...

Evaluation of Glycemic Control and Cost Savings Associated With Liraglutide Dose Reduction at a Veterans Affairs Hospital

PURPOSE: As a result of a cost savings initiative, the Michael E. DeBakey Veterans Affairs Medical Center in Houston, Texas, selected liraglutide as its preferred glucagon-like peptide 1 receptor agonist for the treatment of patients with type 2 diabetes mellitus with a preferred maximum daily dose...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Fed Pract
Main Authors: Imarhia, Fiona I., Malveaux, Janeca N.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontline Medical Communications Inc. 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7592900/
https://ncbi.nlm.nih.gov/pubmed/33132682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12788/fp.0057
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!